Neumora Therapeutics (NMRA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.43, +20.28% vs the prior close of $0.35.
- Volume 6.37M shares, 4.6x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NMRA jumps 20.3% to $0.43 on 4.6x normal volume. Closed at $0.43, +20.28% vs the prior close of $0.35. Day range $0.36–$0.46, opened at $0.37.
NMRA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NMRA jumps 20.3% to $0.43 on 4.6x normal volume
- Closed at $0.43, +20.28% vs the prior close of $0.35. Day range $0.36–$0.46, opened at $0.37.
- Volume was 6.37M shares, 4.6x its 50-day average of 1.40M — unusually heavy trading.
- Price is -59.8% vs its 50-day average ($1.06) and -77.1% vs its 200-day average ($1.87).
- 52-week range $0.31–$3.65; today's close sits at 3% of that range, 88.3% below the 52-week high.
Oct 14, 2026 — NMRA slides 4.1% to $0.35, a 52-week low on 2.1x normal volume
- Closed at $0.35, -4.05% vs the prior close of $0.37. Day range $0.31–$0.40, opened at $0.39.
- Volume was 2.80M shares, 2.1x its 50-day average of 1.36M — unusually heavy trading.
- Price is -67.3% vs its 50-day average ($1.08) and -81.0% vs its 200-day average ($1.87).
- 52-week range $0.31–$3.65; today's close sits at 1% of that range, 90.3% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — NMRA slides 15.3% to $0.37, a 52-week low, 3 down days in a row
- Closed at $0.37, -15.33% vs the prior close of $0.44. Day range $0.37–$0.44, opened at $0.43.
- Volume was 1.49M shares, 1.1x its 50-day average of 1.34M.
- Price is -66.7% vs its 50-day average ($1.11) and -80.3% vs its 200-day average ($1.88).
- 52-week range $0.37–$3.65; today's close sits at 0% of that range, 89.9% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — NMRA slides 8.2% to $0.44, a 52-week low
- Closed at $0.44, -8.19% vs the prior close of $0.48. Day range $0.44–$0.48, opened at $0.48.
- Volume was 1.21M shares, 0.9x its 50-day average of 1.34M.
- Price is -61.5% vs its 50-day average ($1.13) and -76.8% vs its 200-day average ($1.89).
- 52-week range $0.44–$3.65; today's close sits at 0% of that range, 88.0% below the 52-week high.
Oct 9, 2026 — NMRA dips 0.8% to $0.48
- Closed at $0.48, -0.83% vs the prior close of $0.48. Day range $0.47–$0.51, opened at $0.47.
- Volume was 789.40K shares, 0.6x its 50-day average of 1.34M — lighter than usual.
- Price is -58.9% vs its 50-day average ($1.16) and -74.9% vs its 200-day average ($1.89).
- 52-week range $0.45–$3.65; today's close sits at 1% of that range, 87.0% below the 52-week high.
Oct 8, 2026 — NMRA rises 2.6% to $0.48
- Closed at $0.48, +2.56% vs the prior close of $0.47. Day range $0.45–$0.49, opened at $0.46.
- Volume was 1.81M shares, 1.4x its 50-day average of 1.32M.
- Price is -59.4% vs its 50-day average ($1.18) and -74.7% vs its 200-day average ($1.90).
- 52-week range $0.45–$3.65; today's close sits at 1% of that range, 86.8% below the 52-week high.
Oct 7, 2026 — NMRA dips 0.6% to $0.47, a 52-week low on 2.2x normal volume
- Closed at $0.47, -0.64% vs the prior close of $0.47. Day range $0.45–$0.48, opened at $0.47.
- Volume was 2.76M shares, 2.2x its 50-day average of 1.27M — unusually heavy trading.
- Price is -61.2% vs its 50-day average ($1.21) and -75.5% vs its 200-day average ($1.91).
- 52-week range $0.45–$3.65; today's close sits at 1% of that range, 87.2% below the 52-week high.
Oct 6, 2026 — NMRA slides 10.3% to $0.47, a 52-week low
- Closed at $0.47, -10.29% vs the prior close of $0.52. Day range $0.47–$0.54, opened at $0.52.
- Volume was 1.23M shares, 1.0x its 50-day average of 1.27M.
- Price is -61.7% vs its 50-day average ($1.23) and -75.4% vs its 200-day average ($1.91).
- 52-week range $0.47–$3.65; today's close sits at 0% of that range, 87.1% below the 52-week high.
Oct 5, 2026 — NMRA jumps 5.0% to $0.52 on 2.5x normal volume
- Closed at $0.52, +5.00% vs the prior close of $0.50. Day range $0.47–$0.53, opened at $0.50.
- Volume was 2.99M shares, 2.5x its 50-day average of 1.22M — unusually heavy trading.
- Price is -58.1% vs its 50-day average ($1.25) and -72.7% vs its 200-day average ($1.92).
- 52-week range $0.47–$3.65; today's close sits at 2% of that range, 85.6% below the 52-week high.
Oct 2, 2026 — NMRA slides 9.1% to $0.50, a 52-week low on 2.3x normal volume
- Closed at $0.50, -9.09% vs the prior close of $0.55. Day range $0.48–$0.56, opened at $0.56.
- Volume was 2.69M shares, 2.3x its 50-day average of 1.17M — unusually heavy trading.
- Price is -60.7% vs its 50-day average ($1.27) and -74.0% vs its 200-day average ($1.93).
- 52-week range $0.48–$3.65; today's close sits at 1% of that range, 86.3% below the 52-week high.
- That makes 4 straight losses.
NMRA latest news & SEC filings
Every SEC filing by or about NMRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Aurora Daljit Singh sold 20,553 shares at $1.59 (≈$32.68K) on Aug 21, 2026
- Aurora Daljit Singh sold 21,055 shares at $1.60 (≈$33.69K) on Aug 21, 2026
- Aurora Daljit Singh sold 66,711 shares at $1.51 (≈$100.73K) on Aug 20, 2026
- Aurora Daljit Singh sold 67,741 shares at $1.51 (≈$102.29K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$43.08M (prior year -$52.73M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.23 (prior year -$0.33) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade NMRA
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 30, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.71% (largest 20.3%). That is a volatile stock.
- Liquidity: about 2.41M shares (≈$1.03M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.43 vs a range of $0.31–$3.65 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 9 open-market buys, 16 sales; latest: Daljit Singh Aurora sold 20,553 shares on Aug 21, 2026.
- Latest filings: 10-Q Aug 14, 2026; 8-K Aug 14, 2026; 8-K Jul 27, 2026.
- Share count: 187.90M shares outstanding (Aug 10, 2026), +16.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
NMRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.37 | 0.46 | 0.36 | 0.43 | 6.37M |
| Oct 14, 2026 | 0.39 | 0.40 | 0.31 | 0.35 | 2.80M |
| Oct 13, 2026 | 0.43 | 0.44 | 0.37 | 0.37 | 1.49M |
| Oct 12, 2026 | 0.48 | 0.48 | 0.44 | 0.44 | 1.21M |
| Oct 9, 2026 | 0.47 | 0.51 | 0.47 | 0.48 | 789.40K |
| Oct 8, 2026 | 0.46 | 0.49 | 0.45 | 0.48 | 1.81M |
| Oct 7, 2026 | 0.47 | 0.48 | 0.45 | 0.47 | 2.76M |
| Oct 6, 2026 | 0.52 | 0.54 | 0.47 | 0.47 | 1.23M |
| Oct 5, 2026 | 0.50 | 0.53 | 0.47 | 0.52 | 2.99M |
| Oct 2, 2026 | 0.56 | 0.56 | 0.48 | 0.50 | 2.69M |
| Oct 1, 2026 | 0.60 | 0.62 | 0.54 | 0.55 | 2.85M |
| Sep 30, 2026 | 0.68 | 0.69 | 0.59 | 0.60 | 2.28M |
| Sep 29, 2026 | 0.69 | 0.72 | 0.65 | 0.68 | 1.25M |
| Sep 28, 2026 | 0.65 | 0.75 | 0.64 | 0.69 | 3.40M |
| Sep 25, 2026 | 0.69 | 0.71 | 0.63 | 0.68 | 2.32M |
| Sep 24, 2026 | 0.75 | 0.77 | 0.69 | 0.70 | 1.43M |
| Sep 23, 2026 | 0.77 | 0.78 | 0.69 | 0.73 | 1.69M |
| Sep 22, 2026 | 0.70 | 0.81 | 0.69 | 0.78 | 3.21M |
| Sep 21, 2026 | 0.74 | 0.77 | 0.68 | 0.69 | 1.67M |
| Sep 18, 2026 | 0.74 | 0.76 | 0.71 | 0.73 | 3.88M |
About Neumora Therapeutics
Neumora Therapeutics (NMRA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in WATERTOWN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1885522.
NMRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Paul L Berns | See Remarks | Aug 21, 2026 |
| Kristina Burow | Director | May 29, 2026 |
| Matthew K Fust | Director | May 29, 2026 |
| Alaa Halawa | Director | May 29, 2026 |
| Maykin Ho | Director | May 29, 2026 |
| David Piacquad | Director | May 29, 2026 |
| Joshua Pinto | President & CEO | Aug 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Daljit Singh Aurora | See Remarks | Aug 21, 2026 |
| Paul L Berns | See Remarks | Aug 21, 2026 |
| Jason Duncan | See Remarks | Aug 21, 2026 |
| Michael Lee Milligan | See Remarks | Aug 21, 2026 |
| Joshua Pinto | President & CEO | Aug 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Daljit Singh Aurora | Sale | 20,553 | $1.59 |
| Aug 21, 2026 | Daljit Singh Aurora | Sale | 21,055 | $1.60 |
| Aug 20, 2026 | Daljit Singh Aurora | Sale | 66,711 | $1.51 |
| Aug 20, 2026 | Daljit Singh Aurora | Sale | 67,741 | $1.51 |
| Aug 19, 2026 | Daljit Singh Aurora | Sale | 30,918 | $1.65 |
| Aug 19, 2026 | Daljit Singh Aurora | Sale | 31,000 | $1.65 |
| Aug 18, 2026 | Daljit Singh Aurora | Sale | 34,987 | $1.59 |
| Aug 18, 2026 | Daljit Singh Aurora | Sale | 34,162 | $1.58 |
| Aug 17, 2026 | Daljit Singh Aurora | Sale | 55,016 | $1.50 |
| Aug 17, 2026 | Daljit Singh Aurora | Sale | 57,670 | $1.51 |
| Aug 17, 2026 | Daljit Singh Aurora | Sale | 34,020 | $1.49 |
| Feb 17, 2026 | Michael Lee Milligan | Sale | 1,436 | $3.57 |
| Feb 17, 2026 | Joshua Pinto | Sale | 5,967 | $3.54 |
| Feb 17, 2026 | Daljit Singh Aurora | Sale | 6,165 | $3.56 |
| Feb 17, 2026 | Paul L Berns | Sale | 9,819 | $3.51 |
NMRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-236.93M | -1.45 | $-206.44M |
| Dec 31, 2024 | — | $-243.79M | -1.53 | $-182.94M |
| Dec 31, 2023 | — | $-235.93M | -3.63 | $-163.28M |
| Dec 31, 2022 | — | $-130.90M | -4.81 | $-114.90M |
Latest balance sheet: total assets $125.25M, total liabilities $80.73M, cash $116.83M (as of Jun 30, 2026).
NMRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $1.60 |
| May 7, 2026 | 8-K Item 2.02 (results) | $1.94 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $1.93 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.58 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $1.59 |
| May 12, 2025 | 8-K Item 2.02 (results) | $0.69 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $1.40 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $11.31 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NMRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.